NANYOUNG PARK: Open Payments
NPI 1043633084 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,410 in 92 payments from 36 companies in 2025. Trend: 2023 $2,205 · 2024 $2,361 · 2025 $2,410
Food & beverage: $2,315Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $240 |
| Janssen Biotech, Inc. | 7 | $194 |
| Merck Sharp & Dohme LLC | 6 | $189 |
| Daiichi Sankyo Inc. | 5 | $182 |
| BeOne Medicines USA, Inc. | 6 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $120 |
| Astellas Pharma US Inc | 3 | $93 |
| Celgene Corporation | 3 | $90 |
| Incyte Corporation | 4 | $84 |
| Stemline Therapeutics Inc. | 3 | $76 |
Products named: ENHERTU, KEYTRUDA, BRUKINSA, REBLOZYL, TALVEY, Orserdu, RYBREVANT, ELREXFIO.
Industry payments across GA — which companies pay providers there.
